Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Merck
Company Monitoring Page for Merck
latest headlines for company on cafepharma
Merck eyes new bladder cancer space with positive Keytruda trial in muscle-invasive disease
Fierce Pharma
Thu, 10/5/23 - 09:03 pm
Tags:
Merck
,
Keytruda
,
bladder cancer
,
muscle-invasive urothelial carcinoma
US plans shift of Merck COVID treatment to commercial market
Reuters
Thu, 10/5/23 - 10:16 am
Tags:
Merck
,
COVID-19
,
Lagevrio
,
molnupiravir
Sanofi pays Teva $500M to join Merck, Roivant in red-hot bowel disease race
Fierce Biotech
Wed, 10/4/23 - 09:48 am
Tags:
Sanofi
,
Teva Pharmaceutical
,
inflammatory bowl disease
,
IBD
,
Merck
,
Roivant
FDA gives Merck priority review for blood vessel disorder therapy sotatercept
Medical Marketing and Media
Thu, 09/28/23 - 11:42 pm
Tags:
Merck
,
PAH
,
sotatercept
,
FDA
Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo
BioSpace
Fri, 09/22/23 - 11:53 am
Tags:
Merck
,
Seagen
,
Astellas
,
urothelial cancer
,
clinical trials
,
bladder cancer
,
Padcev
,
Keytruda
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Fri, 09/22/23 - 11:46 am
Tags:
Merck
,
Eisai
,
Keytruda
,
Lenvima
,
melanoma
,
colorectal cancer
,
non-small cell lung cancer
Merck (MRK) Keytruda Cervical Cancer sBLA Gets FDA Priority Tag
Yahoo/Zacks.com
Thu, 09/21/23 - 06:32 pm
Tags:
Merck
,
Keytruda
,
FDA
,
cervical cancer
,
priority review
1ST Biotherapeutics and Merck to assess cancer combination treatment
Clinical Trials Arena
Wed, 09/20/23 - 11:09 pm
Tags:
Merck
,
1st Biotherapeutics
,
Keytruda
,
solid tumors
,
clinical trials
HHS argues Merck 'lacks standing' to sue over Medicare price negotiations
Fierce Pharma
Wed, 09/13/23 - 11:38 am
Tags:
Merck
,
Inflation Reduction Act
,
HHS
,
legal
Merck keeps pumping up sotatercept, posting fresh data ahead of FDA approval ruling
Fierce Biotech
Mon, 09/11/23 - 11:54 am
Tags:
Merck
,
sotatercept
,
FDA
,
cardiovascular disease
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
Fri, 09/8/23 - 10:29 am
Tags:
M&A
,
patent cliffs
,
Merck
,
JNJ
,
Pfizer
,
GSK
,
Novartis
,
Eli Lilly
,
Novo Nordisk
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
Tags:
R&D
,
biotech
,
Merck
,
sotatercept
,
Daiichi Sankyo
,
AstraZeneca
,
Dato-DXd
,
Novo Nordisk
,
CagriSema
,
Eli Lilly
,
donanemab
,
Karuna Therapeutics
,
Zai Lab
,
KarXT
,
Moderna Therapeutics
,
mRNA-1647
,
Novartis
,
iptacopan
,
Madrigal Pharmaceuticals
,
resmetirom
,
Cytokinetics
,
aficamten
,
Roche
,
Chugai
,
tiragolumab
5 of the best places to work in pharma, according to employees
Pharma Voice
Tue, 08/29/23 - 11:32 am
Tags:
Glassdoor
,
Merck
,
JNJ
,
Pfizer
,
GSK
,
Sanofi
Merck Initiates Phase 3 Clinical Program for Oral PCSK9 Inhibitor Candidate MK-0616
Drugs.com
Mon, 08/28/23 - 08:23 pm
Tags:
Merck
,
clinical trials
,
MK-0616
,
hypercholesterolemia
Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer
BioSpace
Sun, 08/27/23 - 04:40 pm
Tags:
Merck
,
Eisai
,
Keytruda
,
Lenvima
,
clinical trials
,
head and neck cancer
Merck bets big on oral PCSK9 inhibitor, putting 6-year outcome study at heart of phase 3 program
Fierce Biotech
Fri, 08/25/23 - 09:57 am
Tags:
Merck
,
PCSK9 inhibitors
,
clinical trials
,
cardiovascular disease
,
cholesterol
,
MK-0616
Merck’s Keytruda to top drug sales in 2028, as Roche takes pharma crown
Medical Marketing and Media
Fri, 08/25/23 - 09:55 am
Tags:
Merck
,
Keytruda
,
Roche
,
branding
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
Tags:
patent cliff
,
patents
,
Takeda
,
Vyvanse
,
Pfizer
,
Eraxis
,
JNJ
,
Stelara
,
Merck
,
Isentress
,
Eiger Pharmaceuticals
,
Zokinvy
,
Astellas
,
Myrbetriq
,
Novartis
,
Entresto
,
Amgen
,
Otzela
Merck's Keytruda will top pharma's sales rankings in 2028, with Roche taking the company category crown
Fierce Pharma
Mon, 08/21/23 - 10:43 am
Tags:
Merck
,
Roche
,
pharma sales
,
Keytruda
Merck’s Welireg Clears Phase III Primary Endpoint in Renal Cell Carcinoma
BioSpace
Fri, 08/18/23 - 10:13 am
Tags:
Merck
,
Welireg
,
renal cell carcinoma
,
clinical trials
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.